Preventive Nutrition and Food Science

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Omega-3-Rich Harp Seal Oil on the Production of Pro-Inflammatory Cytokines in Mouse Peritoneal Macrophages

  • Choi, Myungwon (Department of Microbiology, Kosin University College of Medicine) ;
  • Ju, Jaehyun (Department of Food Science and Nutrition, Pusan National University) ;
  • Suh, Jae Soo (Department of Food and Nutrition, Kosin University) ;
  • Park, Kun-Young (Department of Food Science and Nutrition, Pusan National University) ;
  • Kim, Kwang Hyuk (Department of Microbiology, Kosin University College of Medicine)
  • Received : 2014.09.11
  • Accepted : 2015.03.12
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Omega-3, a polyunsaturated fatty acid, is an essential fatty acid necessary for human health, and it protects against cardiovascular disease, inflammation, autoimmune diseases, and cancer. In the present study, we investigated the effects of omega-3-rich harp seal oil (HSO) on the production of nitric oxide (NO) and cytokines, such as tumor necrosis factor (TNF)-${\alpha}$, interleukin-(IL)-$1{\beta}$, IL-6, and IL-12/IL-23 (p40) in peritoneal macrophages of mice. The culture supernatants of murine macrophages exposed to lipopolysaccharide (LPS), HSO, or HSO+LPS were harvested to assay IL-$1{\beta}$, TNF-${\alpha}$, IL-6, and IL-12/IL-23 (p40) cytokines and NO. TNF-${\alpha}$, IL-$1{\beta}$, and IL-12/IL-23 (p40) levels, except IL-6, were lower in the culture supernatants of mouse peritoneal macrophages exposed to LPS plus HSO than those of the groups exposed to LPS alone. These observations demonstrate that omega-3-rich harp seal oil downregulates the production of the pro-inflammatory cytokines such as IL-$1{\beta}$, TNF-${\alpha}$, and IL-12/IL-23 (p40). These results suggest that HSO could be potentially used as a preventive agent or as an adjunct in anti-inflammatory therapy, if more research results were accumulated.

Keywords

References

  1. Dyerberg J, Bang HO, Hjorne N. 1975. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28: 958-966. https://doi.org/10.1093/ajcn/28.9.958
  2. Simopoulos AP. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21: 495-505. https://doi.org/10.1080/07315724.2002.10719248
  3. Calder PC. 2006. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S- 1519S. https://doi.org/10.1093/ajcn/83.6.1505S
  4. Ross R. 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126. https://doi.org/10.1056/NEJM199901143400207
  5. Arrington JL, McMurray DN, Switzer KC, Fan YY, Chapkin RS. 2001. Docosahexaenoic acid suppresses function of the CD28 costimulatory membrane receptor in primary murine and Jurkat T cells. J Nutr 131: 1147-1153. https://doi.org/10.1093/jn/131.4.1147
  6. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. 2001. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged > 55 y. Am J Clin Nutr 73: 539-548. https://doi.org/10.1093/ajcn/73.3.539
  7. Hughes DA, Pinder AC. 2000. n-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes. Am J Clin Nutr 71: 357S-360S. https://doi.org/10.1093/ajcn/71.1.357s
  8. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. 1989. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242: 237-239. https://doi.org/10.1016/0014-5793(89)80476-4
  9. Scott P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260: 496-497. https://doi.org/10.1126/science.8097337
  10. Trinchieri G. 1995. Interleukin-12: a pro-inflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276. https://doi.org/10.1146/annurev.iy.13.040195.001343
  11. Romani L, Puccetti P, Bistoni F. 1997. Interleukin-12 in infectious diseases. Clin Microbiol Rev 10: 611-636.
  12. Cirino G, Distrutti E, Wallace JL. 2006. Nitric oxide and inflammation. Inflamm Allergy Drug Targets 5: 115-119. https://doi.org/10.2174/187152806776383143
  13. Mackman N. 2000. Lipopolysaccharide induction of gene expression in human monocytic cells. Immunol Res 21: 247-251 https://doi.org/10.1385/IR:21:2-3:247
  14. Osuchowski MF, Welch K, Siddiqui J, Remick DG. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177: 1967-1974. https://doi.org/10.4049/jimmunol.177.3.1967
  15. Bhagat K, Vallance P. 1997. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96: 3042-3047. https://doi.org/10.1161/01.CIR.96.9.3042
  16. Simopoulos AP. 2008. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr 17: 131-134.
  17. Robinson DR, Urakaze M, Huang R, Taki H, Sugiyama E, Knoell CT, Xu L, Yeh ET, Auron PE. 1996. Dietary marine lipids suppress continuous expression of interleukin-1${\beta}$ gene transcription. Lipids 31: S23- S31. https://doi.org/10.1007/BF02637046
  18. Woods A, Brull DJ, Humphries SE, Montgomery HE. 2000. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21: 1574-1583. https://doi.org/10.1053/euhj.1999.2207
  19. Kato T, Hancock RL, Mohammadpour H, McGregor B, Manalo P, Khaiboullina S, Hall MR, Pardini L, Pardini RS. 2002. Influence of omega-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett 187: 169-177. https://doi.org/10.1016/S0304-3835(02)00432-9
  20. Fritsche KL, Anderson M, Feng C. 2000. Consumption of eicosapentaenoic acid and docosahexaenoic acid impair murine interleukin-12 and interferon-${\gamma}$ production in vivo. J Infect Dis 182: S54-61. https://doi.org/10.1086/315925
  21. Rockey DC, Chung JJ. 1995. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 95: 1199-1206. https://doi.org/10.1172/JCI117769
  22. Block RC, Dier U, Calderonartero P, Shearer GC, Kakinami L, Larson MK, Harris WS, Georas S, Mousa SA. 2012. The effects of EPA+DHA and aspirin on inflammatory cytokines and angiogenesis factors. World J Cardiovasc Dis 2: 14-19.
  23. Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban MJ, Queralt C, Grau JM, Urbano-Marquez A, Palacin A, Colomer D, Cid MC. 2004. Tissue production of pro-inflammatory cytokines (IL-1${\beta}$, TNF${\alpha}$, and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. Rheumatology 43: 294-301.

Cited by

  1. Anti-B7-H3 monoclonal antibody ameliorates the damage of acute experimental pancreatitis by attenuating the inflammatory response vol.35, 2016, https://doi.org/10.1016/j.intimp.2016.03.013
  2. The Challenge by Multiple Environmental and Biological Factors Induce Inflammation in Aging: Their Role in the Promotion of Chronic Disease vol.11, pp.None, 2015, https://doi.org/10.3389/fimmu.2020.570083